In 2023, the number of hospital discharges for dorsalgia cases in Germany stood at 296.48 thousand. From 2024 to 2028, a steady increase is forecasted, with values reaching 310.76 thousand discharges by 2028. The year-on-year growth rate averages about 1% from 2023 onwards, indicating a gradual but consistent rise in dorsalgia-related hospital discharges. This reflects a compound annual growth rate (CAGR) over the forecast period.
Future trends to watch for include:
- Aging population in Germany, potentially leading to more dorsalgia cases.
- Advancements in medical treatment could reduce hospital stay durations.
- The impact of preventive health measures on reducing dorsalgia incidence.
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...
